Moreover, Chen et al. recently investigated the association between PRKDC mutations and tumor mutation burden (TMB), tumor microenvironment (TME), and response to ICI by integrated analysis of sequencing data of solid tumors in TCGA (n = 4023) and Geneplus (n = 3877) [57]. The gene discussed is PRKDC; the disease is neoplasm.